Incyte (INCY) Cash & Equivalents (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.73% |
| Dec 31, 2025 | 26.18% |
| Sep 30, 2025 | 25.58% |
| Jun 30, 2025 | 0.68% |
| Mar 31, 2025 | 15.04% |
| Dec 31, 2024 | 29.42% |
| Sep 30, 2024 | 32.09% |
| Jun 30, 2024 | -70.50% |
| Mar 31, 2024 | 4.13% |
| Dec 31, 2023 | -0.43% |
| Sep 30, 2023 | 3.07% |
| Jun 30, 2023 | 10.99% |
| Mar 31, 2023 | -4.42% |
| Dec 31, 2022 | 9.69% |
| Sep 30, 2022 | 10.48% |
| Jun 30, 2022 | 7.91% |
| Mar 31, 2022 | 9.69% |
| Dec 31, 2021 | 2.92% |
| Sep 30, 2021 | 11.21% |
| Jun 30, 2021 | 7.64% |
| Mar 31, 2021 | 10.37% |
| Dec 31, 2020 | 1.02% |
| Sep 30, 2020 | 12.89% |
| Jun 30, 2020 | 27.17% |
| Mar 31, 2020 | -43.08% |
| Jun 30, 2019 | 8.97% |
| Mar 31, 2019 | 11.66% |
| Dec 31, 2018 | 4.66% |
| Sep 30, 2018 | 2,474.49% |
| Jun 30, 2018 | -17.40% |
| Mar 31, 2018 | -94.19% |
| Dec 31, 2017 | -20.26% |
| Sep 30, 2017 | 149.70% |
| Jun 30, 2017 | 24.85% |
| Mar 31, 2017 | -44.53% |
| Dec 31, 2016 | 12.45% |
| Sep 30, 2016 | 18.96% |
| Jun 30, 2016 | -25.85% |
| Mar 31, 2016 | 26.12% |
| Dec 31, 2015 | 16.97% |
| Sep 30, 2015 | 1.39% |
| Jun 30, 2015 | 4.23% |
| Mar 31, 2015 | -6.74% |
| Dec 31, 2014 | 18.40% |
| Sep 30, 2014 | -5.97% |
| Jun 30, 2014 | -6.95% |
| Mar 31, 2014 | -7.39% |
| Dec 31, 2013 | 73.24% |
| Sep 30, 2013 | 5.39% |
| Jun 30, 2013 | -2.86% |
| Mar 31, 2013 | 18.64% |
| Dec 31, 2012 | -6.28% |
| Sep 30, 2012 | -7.17% |
| Jun 30, 2012 | 11.09% |
| Mar 31, 2012 | -15.12% |
| Dec 31, 2011 | -12.54% |
| Sep 30, 2011 | -13.02% |
| Jun 30, 2011 | -4.97% |
| Mar 31, 2011 | -9.59% |
| Dec 31, 2010 | 7.49% |
| Sep 30, 2010 | -6.11% |
| Jun 30, 2010 | 2.31% |